SPLENIC ARTERY SYNDROME AFTER LIVER TRANSPLANTATION – PREDICTIVE FACTORS: EXPERIENCE OF A CENTER

Authors

  • Domingues L. Faculty of Medicine of the University of Coimbra, Coimbra, Portugal
  • D. Diogo Adult and Paediatric Liver Transplantation Unit, Coimbra Hospital and University Centre, Portugal
  • P. Donato Medical Image Service, Coimbra Hospital and University Centre, Coimbra, Portugal
  • F. Pereira da Silva Medical Image Service, Coimbra Hospital and University Centre, Coimbra, Portugal
  • R. Martins Adult and Paediatric Liver Transplantation Unit, Coimbra Hospital and University Centre, Portugal
  • P. Oliveira Adult and Paediatric Liver Transplantation Unit, Coimbra Hospital and University Centre, Portugal
  • G. Tralhão Department of Surgery, Coimbra Hospital and University Centre, Portugal
  • E. Furtado Adult and Paediatric Liver Transplantation Unit, Coimbra Hospital and University Centre, Portugal

DOI:

https://doi.org/10.34635/rpc.896

Keywords:

Liver Transplant, Splenic Artery, Embolization, Vascular Diseases

Abstract

Splenic artery syndrome (SAS) is described as a decrease in hepatic artery (HA) flow associated with increased flow in the splenic artery (SA). The present study aim was to identify predictive factors of SAS. A retrospective study was conducted in 70 patients, undergoing liver transplantation (LT) between 03/2010 until 08/2016. The case group (n=27) corresponded to the patients who developed SAS and the control group (n=43) to the patients who didn’t develop. The donor, recipient and graft variables were collected. Significant differences were observed in relation to spleen volume 1137,4±512,9) cm3 vs 523,9±258,1cm3, spleen volume/ liver volume ratio 0,9±0,3 vs 0,4±0,2, difference in caliber between SA and HA 2,1±1,6mm vs 0,8±1,5mm, and the ratio between spleen volume and body mass index (BMI) of the recipient 47,9±24,5 vs 18,9±8,8 between the case and control group respectively. In case group the mean difference between pre-embolization and post-embolization resistive index (RI) was 0.2±0.1, which demonstrates a significant improvement after embolization of the SA (p<0.001, CI: 95% 0.11-0.25). In logistic regression, the retained variable was only the spleen volume (p<0.05), and the cut-off point was 1023.9 cm3. It’s possible to conclude that spleen volume is a risk factor for SAS. It’s also important to note that significant differences between groups were evident in relation to the ratio spleen volume/liver volume and difference in caliber between SA and HA in the pre-LT. In this sense, it’s relevant in future studies to develop a prospective methodological design in order to analyze the predictive value of these variables.

Downloads

Download data is not yet available.

References

1 Quintini C, Hirose K, Hashimoto K, Diago T, Aucejo F, Eghtesad B, et al. Splenic artery steal syndrome is a misnomer: the cause is portal hyperperfusiom, not arterial siphon. Liver Transplant. 2008;14:374–9.

2 Li C, Kapoor B, Moon E, Quintini C, Wang W. Current understanding and management of splenic steal syndrome after liver transplant: A systematic review. Transplant Rev [Internet]. 2017;31(3):188–92. Available from: http://dx.doi.org/10.1016/j.trre.2017.02.002

3 Pinto S, Reddy SN, Horrow MM, Ortiz J. Splenic Artery Syndrome after orthotopic liver transplantation: a review. Int J Surg [Internet]. 2014;12(11):1228–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25311773

4 Saad WE, Anderson CL, Kowarschik M, Turba UC, Schmitt TM, Kumer SC, et al. Quantifying Increased Hepatic Arterial Flow with test balloon occlusion of the splenic artery in liver transplant recipients with suspected splenic steal syndrome: quantitative digitally subtracted angiography correlation with arterial doppler parameters. Vasc Endovascular Surg. 2012;46(5):384–92.

5 Arterial D, Anatomy AS, Arteriography H. Management of Nonocclusive Hepatic Artery Complications After Liver Transplantation. 2007;(1).

6 Garcia-Criado À, Gilabert R, Bianchi L, Vilana R, Burrel M, Barrufet M, et al. Impact of contrast-enhanced ultrasound in the study of hepatic artery hypoperfusion shortly after liver transplantation: contribution to the diagnosis of artery steal syndrome. Eur Radiol. 2014;25(1):196–202.

7 Presser SJ, Podrabsky P, Denecke T, Mogl MT, Nu NC. Evolving experience with prevention and treatment of splenic artery syndrome after orthotopic liver transplantation. 2010;23:831–41.

8 Grieser C, Denecke T, Steffen IG, Avgenaki M, Fröhling V, Mogl M, et al. Multidetector computed tomography for preoperative assessment of hepatic vasculature and prediction of splenic artery steal syndrome in patients with liver cirrhosis before transplantation. Eur Radiol. 2010;20(1):108–17.

9 Saad WEA. Nonocclusive Hepatic Artery Hypoperfusion Syndrome (Splenic Steal Syndrome) in Liver Transplant Recipients. 2012;1(212):140–6.

10 Liu C, Song J, Lu W, Yang J, Jiang L, Yan L, et al. Hepatic Arterial Buffer Response Maintains the Homeostasis of Graft Hemodynamics in Patient Receiving Living Donor Liver Transplantation. Dig Dis Sci [Internet]. 2015; Available from: http://link.springer.com/10.1007/s10620-015-3881-8

11 Presser N, Quintini C, Tom C, Wang W, Liu Q, Diago-Uso T, et al. Safety and Efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience. Liver Transplant. 2015;21:435–41.

12 Fukazawa K, Yamada Y, Nishida S, Hibi T, Arheart KL, Jr EAP. Determination of the safe range of graft size mismatch using body surface area index in deceased liver transplantation. 2013;26(ii):724–33.

Downloads

Published

2021-08-09

Issue

Section

Original Papers

Most read articles by the same author(s)